The aim is to expand the business in synergistic therapeutics areas, to enlarge product portfolio and to increase critical mass in the geopgraphies where Chiesi branches already exist.
In EU Chiesi is focused on expanding business in synergistic therapeutics and development areas Affiliates business opportunities:
Total Staff: ~ 3,800
Commercial Staff : ~ 1,600
Turnover : ~€ 1,100 M
Focus: respiratory, neonatology, transplantology, and rare diseases
In the US, Chiesi is looking for products in the hospital space and in rare diseases. Within the hospital space, the interest lies primarily in acute cardiovascular, hematology, allergy/immunology and nephrology.
Total Staff: ~250
Commercial Staff : ~ 130
Turnover: ~ € 300 M
Focus: hospital setting products (neonatology, acute cardiovascular care and cystic fibrosis)
In emerging countries Chiesi is focused on expanding business in synergistic therapeutic areas and to develop Affiliates business opportunities:
Total Staff: ~1200
Commercial Staff: ~800
Turnover: ~€ 300 M
Focus: respiratory, neonatology, and hospital setting products
